Thank you doesn't seem enough for our melanoma nurses.
28 May 2021
'Sarah is more than a nurse – she’s my supporter, my confidante and my friend. Thank you just doesn’t seem enough.’ - Lauren, melanoma patient
Sarah is one of our much loved nurses who provides direct care and support for our melanoma patients throughout their treatment journey.
Our melanoma nurses care for patients across Sydney, the Riverina and in Western Australia, and provide support for patients in remote and regional areas via telehealth.
No matter what support a patient needs – from post-surgery or clinic support, to guiding through a clinical trial or support in the community – our melanoma nurses are there.
Like Sarah is to Lauren, our nurses become like family.
‘Sarah was the first person I met when I came in for treatment at Melanoma Institute Australia, and from that moment onwards I didn’t feel alone. Cancer is frightening, but Sarah has been my rock. She has been there for all my treatments and all my scans and follow-up appointments. I don’t know how I would have survived it all without her.’ - mother of two, 46 year-old Lauren Walker.
Melanoma Institute Australia has a growing network of nurses to provide support for patients with all stages of melanoma, and also to help educate and raise awareness about melanoma prevention and early detection.
Whilst our research and clinical teams are trialling new treatments to save lives from melanoma, it is our nurses who are on the front line. Quite simply, we couldn’t save lives without them.
‘It was Sarah who I called for re-assurance when I had side effects from treatment. It was Sarah who supported me when I was really unwell in hospital, and it was Sarah who shared my elation when I was told I was finally cancer free,’ - Lauren
‘Thank you just doesn’t seem enough.'
Our melanoma nurses are our unsung heroes who are critical to the care our patients receive in all of our clinics, every day. Without them, we won’t achieve our mission of zero deaths from melanoma this decade.
We need your help to continue funding them, so please donate today for the benefit of all melanoma patients, now and in the future. Any gift you can generously give this tax time will help us continue to fund our melanoma nurses.
Early lymph node check is saving lives in melanoma patients
We are pleased to announce that A/Prof Anne Cust is the new President of the Australasian Epidemiological Association.
More than $3.5 million in competitive funding grants have been awarded to MIA's researchers.
The ESMO conference provided a platform for announcing a number of key melanoma research findings - including practice-changing research from MIA.
Australian researchers have successfully trialled a combination of new treatments to prevent melanoma from spreading to distant organs.
A new treatment that combines an antibody with a cancer-killing virus improves outcomes for patients with advanced melanoma, an international clinical trial has shown.
It feels like groundhog day - another reality TV show, another batch of blatantly sunburnt contestants.
Wouldn’t it be great if your doctor could know if you would respond to treatment before you even had it?
In our latest research update we showcase research in survival estimates, uncover biomarkers, and reveal practice-changing research in surgery and medical oncology.
Senior Clinical Trial Coordinators, like Sarah Lane, support melanoma patients throughout the clinical trial process.
Melanomas are often hard to differentiate from moles. But new technology is helping to improve accuracy of diagnosis.
We are excited to announce that SunSense will proudly be an official supporter of Melanoma Institute Australia. SunSense is an Australian, family owned business.
Five years ago Julie Randall was diagnosed with melanoma and was given months to live. The melanoma had spread throughout her body. The doctors said it was incurable and she’d be lucky if she survived the next nine months. Julie, a patient at Melanoma Institute Australia under Professor Georgina Long was placed on an experimental drug trial. To watch the entire program, visit 9now.com or click here.
Meet our latest Surgical Oncology Fellow, Eva Nagy, to find out more about life as a surgical oncologist, why she came to MIA and what she hopes to achieve.
Melanoma research at ASCO this year focussed on the more precise use of current treatments to ensure optimal treatment for each patient.
MIA recently demonstrated that reflectance confocal microscopy is a useful tool in the clinic to diagnose suspicious-looking lesions in the mouth.
New research is likely to change the way melanoma is managed in many patients by reducing the need for major surgery and its associated morbidity and cost.
Researchers from MIA will present their latest research findings to the world’s largest oncology conference in early June.